Brain-X Science
Brain-X Science
founded in Hong Kong and Beijing, China in October 2022, is composed of more than 500 researchers in brain, neuroscience, and neurology and sponsored by Ainuohui Medical Technology. We dedicate to promoting brain, neuroscience, and neurology's research worldwide. The organization's main goals are to support potential researchers at all stages of their careers, facilitate the exchange of scientific information, improve research infrastructure, and help scientists build platforms for the publication, admission & recruitment, dissemination of their findings and research methods.
About the Journal
Brain-X
is a peer-reviewed, online open access journal that publishes the cutting-edge discoveries and technologies works providing novel insights into all aspects of brain, neuroscience and neurology. Interdisciplinary studies utilizing approaches of mathematics, physics, chemistry, engineering, materials, or information science to address the issues of brain, neuroscience and neurology are particularly encouraged.
Read
more
to learn about the journal.
We cordially invite you to submit manuscripts to Brain-X . The Article Publication Charge is waived for accepted manuscripts from 2023-2025 .
Articles
Music therapy for depression: A narrative review
-  17 August 2024
Graphical Abstract
This review summarizes and classifies the research in recent years and introduces the pathogenesis, diagnosis, and treatment methods of depression. The study of the principles of musical interventions for depression and the practice of musical interventions for depression with various etiologies are highlighted. It is hoped to introduce the progress of depression research and the prospect of music therapy.
Ultrasound‐enabled delivery of drugs to the brain: Thinking outside the blood–brain barrier
-  16 August 2024
Peripheral sensory nerve regeneration: Novel target in bone tissue engineering
-  17 July 2024
Graphical Abstract
This perspective paper introduces the importance of peripheral sensory nerve regeneration in bone healing, a cutting-edge direction in bone tissue engineering. By summarizing the latest knowledge in sensory nerve-bone interplay and the recent advances in biomaterial design for innervated bone tissue regeneration, this paper proposes critical guides for future bone engineering biomaterial design.
Advances of therapy for Alzheimer's disease: An updated review
-  15 July 2024
Graphical Abstract
This article discusses the advancements in the treatment of Alzheimer's disease (AD) from both pharmacological and non-pharmacological perspectives. It elaborates on the advantages and disadvantages of each approach. In summary, the article documents five pharmaceutical treatment methods and five cutting-edge non-pharmacological treatment methods.
A female patient with Alzheimer's disease via multimodality diagnostic approaches: A case report
-  14 July 2024
Recent advances in the pathogenesis, diagnosis, and treatment of sepsis‐associated encephalopathy
- 30 June 2024
Graphical Abstract
Sepsis-associated encephalopathy (SAE), one of the most severe complications of sepsis, presents with diverse clinical symptoms and involves complex pathophysiological mechanisms, making its early diagnosis and targeted treatment challenging. Its pathogenesis primarily arises from inflammation-induced disruption of the blood-brain barrier, aberrant activation and dysfunction of cells, and disturbances in neurotransmitter transmission. Leveraging these pathological insights, integrating biomarkers with existing diagnostic modalities, and targeting core mechanisms hold promise for achieving precise diagnosis and treatment of SAE.
An easy‐to‐follow handbook for electroencephalogram data analysis with Python
- 30 June 2024
Graphical Abstract
This handbook comprises four chapters: Preprocessing Single-Subject Data, Basic Python Data Operations, Multiple-Subject Analysis, and Advanced EEG Analysis. We provide a standardized procedure for preprocessing EEG data, guide readers through detailed examples on how to read data from multiple subjects, and delve into three popular analysis methodologies.
Multimodal diagnostic approaches in a male patient with hydrocephalus indicated by widening of the temporal horns of the lateral ventricles: A case report
- 29 June 2024
Why we need neurodiversity in brain and behavioral sciences
-  25 June 2024
Graphical Abstract
This article advocates for the neurodiversity paradigm as a crucial framework in brain and behavioral sciences, challenging the deficit-focused medical model. It emphasizes the recognition of neurocognitive variances—such as autism, ADHD, and dyslexia—as natural human diversity, urging a shift in research and practice towards valuing neurodivergent strengths and promoting inclusivity. The authors call for an integrated approach in research, policy, and societal attitudes to celebrate all forms of cognitive functioning as part of human advancement.
The L1CAM-positive extracellular vesicle-based biomarker as a promising predictor of Parkinson's disease
-  24 June 2024
High‐density implantable neural electrodes and chips for massive neural recordings
-  20 June 2024
Graphical Abstract
High-density neural recordings with superior spatiotemporal resolution are powerful in unveiling cellular-scale neural communication for cutting-edge neuroscience discoveries and applications. The number of channels in both electrodes and chips has grown from a few to thousands or even tens of thousands in recent decades. By bridging the breakthroughs between electrodes and chips, more evolutionary tools for brain-wide recordings will be boosted at a fast pace.
Comprehensive review of Transformer‐based models in neuroscience, neurology, and psychiatry
-  26 April 2024
Graphical Abstract
This comprehensive review introduces the transformative role of transformer-based models in neuroscience, neurology, and psychiatry. It discusses how these models, originally designed for sequential data analysis, have evolved to effectively analyze complex biomedical data, significantly enhancing our understanding of brain functions and dysfunctions.
COVID‐19 and cognitive impairment: From evidence to SARS‐CoV‐2 mechanism
-  16 April 2024
Graphical Abstract
The impact of SARS-CoV-2 extends beyond respiratory effects. It may invade the brain through diverse pathways, affecting cognitive functions via both immune and nonimmune mechanisms. Its infection initiates a cascade of effects disrupting the intricate inflammatory network in the central nervous system, exacerbating disease progression.
Positron emission tomography imaging of the P2X7 receptor with a novel tracer, [18 F]GSK1482160, in a transgenic mouse model of Alzheimer's disease and healthy non-human primates
- 22 March 2024
Graphical Abstract
We have developed a novel PET tracer, [18 F]GSK1482160, and verified its permeability and stability to the blood-brain barrier (BBB) in both rodents and non-human primates using PET imaging techniques. The correlation between the binding of [18 F]GSK1482160 and Morris water maze (MWM) behavioral analysis suggests that neuroinflammatory regions are susceptible to cognitive impairment in Alzheimer's disease (AD) mice.
Synchronous hybrid brain–computer interfaces for recognizing emergency braking intention
- 21 March 2024
Graphical Abstract
A hybrid brain–computer interface (BCI) combining electroencephalography (EEG) with electromyography (EMG) can be effectively utilized to leverage the advantages of the stable predictive power of EEG and the direct correlation of EMG with braking actions for recognizing emergency braking intention from normal driving and soft braking. In this study, four different fusion strategies based on the spectral band and spectral point features were attempted from the perspective of the feature and classifier level. Offline and pseudo-online experimental results demonstrated the effectiveness of the proposed methods.
Network insights: Transforming brain science and mental health through innovative analysis
- 7 March 2024
Prospects of antidiabetic drugs in the treatment of neurodegenerative disease
- 29 February 2024
Graphical Abstract
Neurodegenerative diseases (NDs) are rising globally, notably due to an aging population, and current therapeutic options are limited despite extensive research. Type 2 diabetes mellitus (T2DM) is linked to cognitive decline in NDs, and certain antidiabetic drugs, such as glucagon-like peptide-1 receptor agonists and metformin, show potential neuroprotective effects beyond their primary use. This review explores the neuroprotective capabilities of these antidiabetic drugs, investigating mechanisms such as reducing protein aggregation and oxidative stress and concludes with an overview of clinical trials evaluating these drugs for treating ND.
β2-microglobulin: An essential coaggregation factor with β-amyloid in amyloid pathology
- First Published: 13 December 2023
Flexible, ultrathin bioelectronic materials and devices for chronically stable neural interfaces
- First Published: 11 December 2023
This review summarizes recent advances in engineered materials, device designs, and integration schemes for neural interfaces which facilitate brain signal recording and stimulation and offer long-term, stable, high-channel-count, and high-resolution operation. The advances summarized in this review will guide the future direction of this technology and provide a basis for next-generation chronic neural interfaces with long-lived high-performance operations.
Atomically bio‐plausible neuron toward complex neuromorphic applications
- 10 December 2023
The antianxiety effects of koumine and gelsemine, two main active components in the traditional Chinese herbal medicine Gelsemium : A comprehensive review
- 10 December 2023
Graphical Abstract
This article reviews the antianxiety effects of the Chinese herbal medicine Gelsemium under different test conditions and discusses recent advances in the antianxiety mechanisms of its two alkaloids, confirming the antianxiety potential of Gelsemium alkaloids. This review will provide theoretical support for pharmacological research on Gelsemium , contribute to developing and applying Gelsemium -based drugs, help the treatment of anxiety disorders, and promote the development of medicine.
TurboID coupled with APEX2: Application prospects for deciphering proteome trafficking and interactions in neuroscience
- 7 December 2023
Calcitonin gene‐related peptide and persistent corneal pain: A trigeminal nerve sensitization perspective
- 6 December 2023
Graphical Abstract
High calcitonin gene-related peptide (CGRP) levels cause central sensitization, which may be associated with the overactivation of glial cells and various pain receptors. CGRP induces MAPK14 activation and nitric oxide (NO) secretion on the surface of neurogliocytes, and the produced NO stimulates CGRP secretion through the N-type calcium channel. CGRP increases N -methyl-d-aspartate and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors on the postsynaptic membrane.
Sonogenetics as a promising approach for non‐invasive ultrasound neuromodulation of deep neural circuits
- 3 December 2023
Anchoring neurostimulation on crossed cerebellar diaschisis for motor recovery in adults with hemiparesis
- 2 December 2023
Virtual external stimulation promotes the transformation of the brain state from early mild cognitive impairment to health
- 29 November 2023
Graphical Abstract
To evaluate how external stimulation of brain regions affects the brain state, our study used the exact controllability theory to determine potential targets and applied a whole-brain dynamic model via virtual stimulation to promote the transformation of the brain state from early mild cognitive impairment (EMCI) to health. The findings reveal the underlying brain mechanisms of cognitive decline in patients with EMCI, which could help in designing more effective therapeutic interventions.
Advancements and implications of semantic reconstruction of continuous language from non‐invasive brain recordings
- 17 October 2023
Latent embeddings: An essential representation of brain–environment interactions
- 17 October 2023
Understanding the brain with attention: A survey of transformers in brain sciences
- 12 October 2023
Graphical Abstract
This survey provides a comprehensive review of the development and application for Transformers in brain sciences. It covers eight widely concerned brain science scenarios to provide vital details and discussions for the latest Transformer researches. By exploring the current challenges and potential research directions, it would be expected to provide a convenient reference for researchers in related fields.
Understanding the role of inflammation in sensorineural hearing loss: Current goals and future prospects
- 12 October 2023
Graphical Abstract
This paper describes the role of inflammation in sensorineural hearing loss (SNHL). Inflammation affects SNHL primarily via cochlear immunity, microcirculation, vasospasm, and glutamate metabolism, often accompanied by immune cell infiltration, altered blood flow, ischemic damage, and synaptic injury. A comprehensive anti-inflammatory approach is undesirable, and studying inflammation-related mechanisms will aid the search for potential targets in SNHL.
Edge‐centric functional network reveals new spatiotemporal biomarkers of early mild cognitive impairment
- 12 October 2023
Graphical Abstract
In contrast to existing studies that focus on the correlations between brain regions, our study is based on the high-order edge network and innovated to explore the correlation between brain region pairs from the perspective of space and time, search for new biomarkers, and explore the pathogenesis of early mild cognitive impairment, which is conducive to delaying its development to Alzheimer's disease and promoting medical developments.
Reactive oxygen species targeted biomaterials for spinal cord injury therapy
- 10 October 2023
Graphical Abstract
This review provides an extensive overview of the recent advancements in reactive oxygen species (ROS)-targeted biomaterials tailored for spinal cord injury (SCI) treatment, emphasizing their ability to effectively clean excessive ROS, modulate inflammation, and reduce secondary injuries. The review also showcases their potential for future translational research involving SCI clinical therapies, which will enable the ongoing enhancement and optimization of these biomaterials to benefit individuals with SCIs.
Novel brain‐inspired optomemristive feedback neuron for neuromorphic computing
- 4 October 2023
Understanding the heterogeneous immune repertoire of brain metastases for designing next‐gen therapeutics
- 1 October 2023
Graphical Abstract
Advanced cancer patients often develop brain metastases, but their molecular and immunological features remain poorly understood due to challenges in biopsy. This perspective highlights recent advances in immune landscape profiling of brain metastases, with an emphasis on tumor-reactive T cells, and summarizes innovative technologies for tracking tumor dynamics and designing targeted therapies.
The mechanism of bone healing after traumatic brain injury
- 28 September 2023
Direct neuronal reprogramming for central nervous system regeneration
- 28 September 2023
ChatGPT: The cognitive effects on learning and memory
- 20 September 2023
Graphical Abstract
The integration of ChatGPT into the domains of learning and memory holds the potential to transform the entire field of education. This article explores the potential positive and negative effects of increased engagement with artificial intelligence, offering strategies for optimizing its benefits while mitigating its drawbacks, and highlights areas that can benefit from further research. In this way, it seeks to ensure that ChatGPT operates as an adjunctive educational tool that complements human cognitive processes without damaging them.
Prediction of the hand function part of the Fugl‐Meyer scale after stroke using an automatic quantitative assessment system
- 22 August 2023
Graphical Abstract
This study aims to quantitatively assess the motor function of the hand in stroke patients with a self-developed system named the Hand Automatic Quantitative Assessment System (HAQAS) using state-of-the-art machine learning algorithms. There were high correlations between features automatically collected by the HAQAS and Fugl-Meyer scales in all the sub-items. Our proposed automatic FMA system is easy and transparent to use in clinical settings and would greatly reduce the workload of physical therapists and clinicians.
Target localization intervention and prognosis evaluation for an individual with mild cognitive impairment
- 22 August 2023
Graphical Abstract
A single brain region state dynamics model was developed to simulate blood oxygen level-dependent signals of a patient with early mild cognitive impairment. Multiple complex network centralities were comprehensively considered to locate the intervention targets, and a multi-brain collaborative control scheme was designed and verified at the brain region and subnetwork levels.
Heart–brain team approach of acute myocardial infarction complicating acute stroke: Evidencing the knowledge gap
- 15 August 2023
Nanomedicines for Alzheimer's disease: Therapies based on pathological mechanisms
- 28 July 2023
Tribo-ferro-optoelectronic neuromorphic transistor of α -In2 Se3
- 18 July 2023
Graphical Abstract
This paper proposes a tribo-ferro-optoelectronic neuromorphic transistor with multimodal synaptic plasticity by combining a triboelectric nanogenerator and a two-dimensional ferroelectric α-In2 Se3 transistor. The device enables associative learning and Boolean logic through the synergy of mechanical displacement, ferroelectric polarization, and light illumination.
Potential roles of transformers in brain tumor diagnosis and treatment
-  13 July 2023
Graphical Abstract
Transformers play an essential role in the brain tumor segmentation of MRI images, the MRI- and histopathology-based grading of brain cancer, brain tumor molecular expression prediction, the classification of primary brain metastasis sites, voxel-level dose and brain tumor radiotherapy outcome prediction, synergistic prediction, and the pathway deconvolution of drug combinations. This review aimed to discuss the increasing applications of Transformers in real-time brain tumor detection and therapy, indicating their broad prospects and potential.
Functional magnetic resonance imaging study of children's brain development in phonological processing and speeded naming
-  10 July 2023
Revolutionary delivery system enables precise protein transportation
-  29 June 2023
SPEAC‐seq: A new method to investigate astrocyte‐microglia crosstalk
-  28 June 2023
A new mechanism of consciousness recovery from anesthesia regulated by K+ -Cl– cotransporter KCC2
-  1 June 2023
The oscillating mystery: The effects of forty-hertz entrainment in treating Alzheimer's disease
-  30 May 2023
Waking up neural stem cells through inhibition of mitochondrial pyruvate import
-  29 May 2023
Novel mechanism of DNA repair in neurons opens promising avenues for combatting neurodegenerative diseases and brain aging
-  19 May 2023
3D printing‐based full‐scale human brain for diverse applications
-  5 April 2023
Graphical Abstract
This paper aims to develop a set of three-dimensional (3D) printing approaches to fabricate customized full-scale human brain models for surgery training as well as specialized brain patches for wound healing after surgery. Brain patches with complex geometries can be directly printed in a stimuli-responsive yield-stress support bath, while full-scale human brain models are created by an inverse fabrication strategy.
3‐hydroxybutyrate in the brain: Biosynthesis, function, and disease therapy
-  27 March 2023
Nucleic acid delivery by ionizable nanocarriers for brain disease treatment
-  26 March 2023
Brain-X: A new interdisciplinary journal for advancing neuroscience research
- 21 March 2023
Systolic pressure target after endovascular thrombectomy in acute large-vessel occlusion ischemic stroke patients: Comment on ENCHANTED2/MT
- 21 March 2023
Rhythmic calcium ion activity related to glioma growth reveals the mechanism of ion transmission
-  21 March 2023
more
The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.
Nanomedicines for Alzheimer's disease: Therapies based on pathological mechanisms
- 28 July 2023
Recent issues
-
Volume 2, Issue 2June 2024
-
Volume 2, Issue 1March 2024
-
Volume 1, Issue 4December 2023
-
Volume 1, Issue 3September 2023
-
Volume 1, Issue 21 June 2023
-
Volume 1, Issue 1March 2023